PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Eversheds advises CBPE Capital on GBP225m sale

Law firm Eversheds has advised mid-market private equity firm CBPE Capital on the sale of IDIS Group Holdings to Clinigen Group for an Enterprise Value of GBP225m.

The transaction represents a money multiple of 22x CBPE’s GBP9.4m investment in IDIS.
IDIS is the global leader in providing regulatory and ethically compliant access to unlicensed medicines for healthcare professionals and their patients with unmet medical needs.

The Eversheds team was led by Partner and head of private equity Richard Moulton, assisted by Principal Associate Louise Finnie and Associate Andy Lord. Share options advice was provided by Partner Danny Blum and Associate Richard Sharman.

Moulton says: “As the private equity industry becomes increasingly buoyant, we are pleased to have assisted CBPE on this significant deal which is in line with its overall strategy. We look forward to working with the team on future transactions.”

Sean Dinnen of CBPE, says: “The Eversheds team have provided first class support to CBPE throughout the period of our investment in IDIS.  The firm originated the opportunity for us, have given full service support to the IDIS group throughout our tenure and have done an excellent job in helping us successfully execute this transaction.”

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured